Site Search

Share

X

Search Results

Maryland Lawmakers Overwhelmingly Support Increasing Access to Biomarker Testing

... passage in the Senate and House of Delegates and representing a victory for cancer patients across Maryland. The legislation aims to ensure biomarker testing is covered by all state-regulated health plans, including Medicaid, when it is supported by medical and scientific evidence. With the Governor’s signature, more Marylanders will benefit from biomarker testing, a critical step in accessing precision medicine services. Dubbed ‘the right treatment at the right time,’ precision medicine ...

The Landscape of Biomarker Testing Coverage in the U.S.

Biomarker testing is becoming increasingly important for cancer care because it connects the right patient, to the right treatment, at the right time, however insurance coverage of testing varies widely. This study, that examines administrative claims data to understand the premium impact of expanding biomarker testing coverage in four markets: commercial self-insured large group, small group, individual, and Medicaid, found a small potential ...

Sign to Expand Access to Biomarker Testing in Maine

Add your voice to our petition to support legislation that would expand health insurance coverage of biomarker testing in Maine. 0 Sign to Expand Access to Biomarker Testing in Maine ...

Sign to Expand Access to Biomarker Testing in Vermont

Add your voice to our petition to support legislation that would expand health insurance coverage of biomarker testing in Vermont. 0 Sign to Expand Access to Biomarker Testing in Vermont ...

Rhode Island Senate Votes to Remove Barriers to Biomarker Testing

PROVIDENCE –Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s ...

Biomarker Testing Bill Passes Senate Committee, Advances to Senate Floor

Earlier this morning, House Bill 1754 was voted out of the Senate Banking & Insurance Committee. This legislation, which aims to ensure that biomarker testing is covered by Medicaid and all other state-regulated insurance plans when patients need it, now advances to the Senate floor for consideration. Biomarker testing is a precision medicine tool that utilizes information from patients’ disease cells to determine the right treatment at the ...

Sign to Expand Access to Biomarker Testing in New Hampshire

Add your voice to our petition to support legislation that would expand health insurance coverage of biomarker testing in New Hampshire. 0 Sign to Expand Access to Biomarker Testing in New Hampshire ...

Gov. Moore Approves Legislation to Expand Access to Biomarker Testing

... Gov. Wes Moore will be signing HB 1217 / SB 805—among many other bills—into law. This legislation will increase insurance coverage for biomarker testing, making this form of precision medicine available to more Marylanders. The signing ceremony will take place today at 12:00pm in the State ... champions who saw HB 1217 / SB 805 to the finish line. For more information on precision medicine, cancer biomarkers, current barriers to biomarker testing and ACS CAN’s policy recommendations, visit:  www.fightcancer.org/biomarkers . ###  About ACS CAN The American Cancer Society ...

Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing

Pharmacogenomic (PGx) testing (also known as pharmacogenomic biomarker testing) is a component of precision medicine that involves examining a patient’s inherited genes to detect variations that may impact the way a ... treatment given to patients with the same disease can produce different responses based on each person's inherited genes. Pharmacogenomic (PGx) Testing: Tests Guide Appropriate Drug Selection and Dosing ...

Bill Increasing Access to Biomarker Testing for Certain Coloradans Becomes Law

... law during a ceremony at the Governor’s Mansion on Monday afternoon, ensuring more Colorado patients with private insurance have coverage for biomarker testing . The American Cancer Society Cancer Action Network (ACS CAN) recognizes the signing of the bill as a positive first step to increasing access to biomarker testing to connect patients with the right treatment at the right time. During Monday’s ceremony, Governor Polis was surrounded by ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy